New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ...

The American Lung Association released its eighth annual State of Lung Cancer report this past week, noting the five-year survival rate has gone from 18% to nearly 30% in under a decade. But more ...

Lung cancer is the second most common cancer and the leading cause of cancer death in the United States. A combination of factors contributes to lung cancer, including air pollution, exposure to radon ...

Lung cancer screening was associated with earlier-stage diagnoses and improved survival in a retrospective analysis of a large cohort with low screening uptake. Randomized trials have shown a ...

Significant progress is being made in the fight against lung cancer, according to a new study from the American Lung ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

A new randomized trial from North Carolina suggests that digital tools like mPATH may slightly boost participation in CT lung ...